Skip to main content
OpenTrials
Completed

NCT Number: NCT03064724

Practice-based Intervention for Vietnamese and Korean Patients

This pilot project examined the feasibility of an multilingual interactive video education intervention "an interactive Mobile Doctor intervention (iMD)" to promote patient-provider discussion on tobacco use for Korean- and Vietnamese-speaking male patients at primary care settings.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

About this study

While California has made significant strides in tobacco control and is leading the nation in reducing smoking use, the decline is not observed in all groups. Select groups still have much higher smoking rates and thus bear an unequal burden of tobacco-related illnesses and deaths. Of important note, Asian American men as a combined group have a higher smoking rate than non-Hispanic Whites (22% vs. 18%, respectively); in particular, the highest smoking prevalence has been observed in Vietnamese (31%) and Korean (30%) men among major Asian subgroups. Research also shows that smoking rates are higher for Asian American men with low acculturation (e.g., immigrant status, low English proficiency) than for those who are more acculturated; yet the reverse trend is observed in Asian American women. These findings underscore the need for more targeted tobacco control efforts. The scientific literature suggests that provider advice to quit smoking can influence a smoker's decision to quit. However, research has shown that Asian Americans are less likely to receive such provider advice. Providers often have very limited face-time with patients during the short clinic visit, which presents a challenge as to whether they can incorporate smoking cessation messages during the visit. Overall, little research has focused on smoking cessation in the clinic setting, particularly research that focuses on Asian Americans. The purpose of the pilot study was to develop a more streamlined smoking cessation intervention that can be integrated into the clinic visit, especially to maximize the time when patients are waiting to see their providers. The research question was whether providing culturally appropriate video education that includes provider advice and was tailored to a patient's readiness for quitting smoking will increase whether a patient receives smoking cessation education according to the recommended Clinical Practice Guideline and whether this results in a decrease in tobacco use in low-income Vietnamese and Korean patients. Using a community-based participatory research approach, the investigators created the iMD that delivers tailored in-language video messages via a mobile tablet to Korean and Vietnamese male smokers right before their clinic visit with a provider. iMD delivers the "5 A's" and generates a bilingual tailored printout. Participants were Korean- and Vietnamese-speaking patients who self-identify as daily smokers and receive primary care at a federally-qualified health center. This study evaluated the feasibility and acceptability of iMD from the patients' perspectives. This study examined patient-provider discussion on tobacco use from patients' self-report and electronic health record (EHR), and self-reported quit attempts and smoking abstinence at 3 months post iMD visit.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • current smokers identified on electronic health records (EHR)
  • have a scheduled primary care visit during the recruitment period

Exclusion criteria

  • already quit smoking or not smoking daily in the past 7 days
  • had already quit smoking or not smoking daily in the past 7 days
  • had canceled or rescheduled their primary care visit outside of the study period

Treatment and study plan

Interactive Mobile Doctor ("iMD")

Behavioral

iMD delivers tailored interactive video education via a mobile tablet to smoking patients right before their clinic visit with a provider. iMD delivers the "5 A's" (ask, advise, assess, assist, and arrange) and generates a bilingual tailored printout, which aims to increase patient-provider discussion on tobacco use and to promote smoking cessation. This version of iMD delivers the intervention in Korean or Vietnamese languages as preferred by the patient.

Primary outcomes

  1. Participation Rate

    Time frame: Baseline

    proportion of eligible participants consent to participate

  2. Acceptability

    Time frame: through study completion, an average of 1 year

    proportion of participants who rated the intervention as moderately to extremely satisfied

Secondary outcomes

  1. Patient-provider discussion

    Time frame: "through study completion, an average of 1 year

    self-reported by patient whether discussion on tobacco use took place at the indexed clinical encounter

  2. Physician delivery of 5As

    Time frame: "through study completion, an average of 1 year

    EHR-documented physician's delivery of assess, advice, assist, or arrange at the indexed clinical encounter

  3. Quit attempt

    Time frame: 3-month

    self-reported at least one or more 24 hour quit attempts

  4. Abstinence

    Time frame: 3-month

    self-reported 7-day point prevalent smoking abstinence

Sponsors and collaborators

Lead sponsor

Asian Health Services

Other

Collaborators

  • University of California, San Francisco

Registry information

Important dates

Study start
2012
Primary completion
2015
Study completion
2015
First posted
Feb 27, 2017
Registry last updated
Feb 27, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.